Ramoil Management, Ltd Announces RAMO Bio-Med Facebook Page & CBD Clone Production Photos
LAS VEGAS, Nov. 24, 2014 /PRNewswire/ -- RAMOIL MANAGEMENT, Ltd (OTCPink: RAMO) announces that RAMO Bio-Med, Inc., its wholly owned subsidiary, has a new Facebook page showing pictures of its CBD Clones, scheduled for mid-January, 2015 harvest, to be used in Q1-2015 "RAMO CBD Pain" and "RAMO CBD Sleep" product production.
Michael Goeree, Ramoil Management's Chairman, President and Chief Executive Officer, said: "Per our November 18, 2014 press release "RAMO Bio-Med, Inc. is presently ramping up production", we believe that pictures are far better than words and our present and future shareholders would appreciate the visual update in progress, as well."
Mr. Goeree further stated: "On this Facebook page, I will be periodically posting comments and answering questions, so please stay involved."
About Ramoil Management, Ltd.
Ramoil Management, Ltd. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containing nutraceutical vapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients. Through its wholly owned subsidiary, RAMO Bio-Med, Inc., it is operating a "Supercritical CO2 Molecular Extraction" system and is planning to build production facilities and research labs, both domestically and internationally, focused on its own proprietary strain of high CBD – extremely low THC Extraction Facilities (Labs and Manufacturing), for the development, production and sales of CBD extractions, concentrates and medicines.
Forward Looking Statements:
This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
Company and Investor Relations Contact:
Frank Blainey, Esq. at: +1-702-381-1961
[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ramoil-management-ltd-announces-ramo-bio-med-facebook-page--cbd-clone-production-photos-300000138.html
SOURCE Ramoil Management, Ltd.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article